Effects of early experience and dexamethasone on adrenocortical reactivity

Insights

Early life shock does not alter long-term adrenocortical reactivity via maternal or infant hormone changes. Blocking adrenocortical responses with dexamethasone in infant rats showed no mediation by circulating hormones.

Area of Science:

  • Neuroendocrinology
  • Developmental Psychology
  • Behavioral Science

Background:

  • Early life stress is known to have long-term effects on the neuroendocrine system.
  • The role of adrenocortical hormones in mediating these effects is not fully understood.

Purpose of the Study:

  • To test the hypothesis that changes in circulating adrenocortical hormones mediate the long-term effects of early life shock.
  • To investigate the involvement of both maternal and infant adrenocortical responses.

Main Methods:

  • Infant rats were exposed to peripheral shock stimulation.
  • Dexamethasone was administered to mothers via drinking water to block adrenocortical responses in both mothers and pups.
  • Control experiments confirmed dexamethasone presence in pups.

Main Results:

  • Shock exposure reduced adrenocortical reactivity regardless of whether the mother, the young, or both could mount an adrenocortical response.
  • Dexamethasone effectively blocked adrenocortical responses to shock stimulation.

Conclusions:

  • The findings do not support the hypothesis that pituitary-adrenocortical responses in either the mother or the infant mediate the effects of early life stimulation on subsequent adrenocortical reactivity.
  • Alternative mechanisms may underlie the long-term effects of early life stress on adrenocortical function.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...